Nebivolol Protects against Myocardial Infarction Injury via Stimulation of Beta 3-Adrenergic Receptors and Nitric Oxide Signaling
Open Access
- 21 May 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5), e98179
- https://doi.org/10.1371/journal.pone.0098179
Abstract
Nebivolol, third-generation β-blocker, may activate β3-adrenergic receptor (AR), which has been emerged as a novel and potential therapeutic targets for cardiovascular diseases. However, it is not known whether nebivolol administration plays a cardioprotective effect against myocardial infarction (MI) injury. Therefore, the present study was designed to clarify the effects of nebivolol on MI injury and to elucidate the underlying mechanism. MI model was constructed by left anterior descending (LAD) artery ligation. Nebivolol, β3-AR antagonist (SR59230A), Nitro-L-arginine methylester (L-NAME) or vehicle was administered for 4 weeks after MI operation. Cardiac function was monitored by echocardiography. Moreover, the fibrosis and the apoptosis of myocardium were assessed by Masson's trichrome stain and TUNEL assay respectively 4 weeks after MI. Nebivolol administration reduced scar area by 68% compared with MI group (p<0.05). Meanwhile, nebivolol also decreased the myocardial apoptosis and improved the heart function after MI (p<0.05 vs. MI). These effects were associated with increased β3-AR expression. Moreover, nebivolol treatment significantly increased the phosphorylation of endothelial NOS (eNOS) and the expression of neuronal NOS (nNOS). Conversely, the cardiac protective effects of nebivolol were abolished by SR and L-NAME. These results indicate that nebivolol protects against MI injury. Furthermore, the cardioprotective effects of nebivolol may be mediated by β3-AR-eNOS/nNOS pathway.Keywords
This publication has 24 references indexed in Scilit:
- Cardioprotective Effect of Beta-3 Adrenergic Receptor Agonism: Role of Neuronal Nitric Oxide SynthaseJournal of the American College of Cardiology, 2012
- β3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ currentJCI Insight, 2008
- β3-Adrenergic eNOS stimulation in left ventricular murine myocardiumCanadian Journal of Physiology and Pharmacology, 2006
- β3-Adrenoceptors in the cardiovascular system: Putative roles in human pathologiesPharmacology & Therapeutics, 2006
- ?-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human ?-adrenergic receptorCardiovascular Research, 2003
- β-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart FailureCirculation, 2003
- Trends in the Incidence and Survival of Patients with Hospitalized Myocardial Infarction, Olmsted County, Minnesota, 1979 to 1994Annals of Internal Medicine, 2002
- Upregulation of β 3 -Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing MyocardiumCirculation, 2001
- Congestive heart failure: fifty years of progress.Circulation, 2000
- β3-adrenoceptor deficiency blocks nitric oxide–dependent inhibition of myocardial contractilityJCI Insight, 2000